Luxor Capital Group’s Myriad Genetics MYGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-1,815,341	Closed	-$62.1M	–	39
2014 Q1	$62.1M	Sell	1,815,341 -1,483,107	-45%	-$50.7M	1.22%	20
2013 Q4	$69.2M	Buy	3,298,448 +2,894,448	+716%	+$60.7M	1.11%	16
2013 Q3	$9.49M	Buy	+404,000	New	+$9.49M	0.13%	27